Phase II Study of HMPL-004 in Patients With Ulcerative Colitis

NCT00659802 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: HMPL-004 low dose
DRUG: Placebo
DRUG: HMPL-004 high dose

Sponsor

Hutchison Medipharma Limited